Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.
Sanjay SethiJames F DonohueGary T FergusonChris N BarnesGlenn D CraterPublished in: Therapeutic advances in respiratory disease (2021)
NCT02512510, NCT02459080, NCT02518139 The reviews of this paper are available via the supplemental material section.